In this article the author discuss strategies to standardize data across clinical trials, to integrate clinical and biological data and to make data and supporting information broadly accessible. They describe, in detail, efforts at their institution to implement an integrated database system for the discovery of biomarkers in autoimmune disease, including examples of analyses performed using the system.